Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Brand names: RYSTIGGO
12.1 Mechanism of Action Rozanolixizumab-noli is a humanized IgG4 monoclonal antibody that binds to the neonatal Fc receptor (FcRn), resulting in the reduction of circulating IgG.
Contraindications
10 documented side effects by frequency
No community discussions found for ROZANOLIXIZUMAB yet.
0 available comparisons
No comparisons yet.
Dosage Forms
Tablet
Route
Subcutaneous